-
Fund Dashboard
- Holdings
EQ/T.Rowe Price Health Sciences Portfolio
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
LLY Eli Lilly and Company | 16.86 mm | 21.84 k shares | 10.26 | Common equity | Long | USA |
UNH UnitedHealth Group Incorporated | 10.02 mm | 19.80 k shares | 6.10 | Common equity | Long | USA |
ISRG Intuitive Surgical, Inc. | 9.61 mm | 18.41 k shares | 5.85 | Common equity | Long | USA |
TMO Thermo Fisher Scientific Inc. | 7.57 mm | 14.56 k shares | 4.61 | Common equity | Long | USA |
SYK Stryker Corporation | 6.92 mm | 19.23 k shares | 4.21 | Common equity | Long | USA |
DHR Danaher Corporation | 6.19 mm | 26.98 k shares | 3.77 | Common equity | Long | USA |
Argenx SE
|
6.10 mm | 9.92 k shares | 3.71 | Common equity | Long | Netherlands |
MRK Merck & Co., Inc. | 4.23 mm | 42.51 k shares | 2.57 | Common equity | Long | USA |
BSX Boston Scientific Corporation | 4.18 mm | 46.75 k shares | 2.54 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals Incorporated | 3.96 mm | 9.84 k shares | 2.41 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals, Inc. | 3.83 mm | 16.28 k shares | 2.33 | Common equity | Long | USA |
AstraZeneca plc
|
3.47 mm | 52.98 k shares | 2.11 | Common equity | Long | UK |
ELV Elevance Health Inc. | 3.12 mm | 8.46 k shares | 1.90 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 3.04 mm | 4.27 k shares | 1.85 | Common equity | Long | USA |
AMGN Amgen Inc. | 2.52 mm | 9.68 k shares | 1.54 | Common equity | Long | USA |
INSM Insmed Incorporated | 2.35 mm | 34.06 k shares | 1.43 | Common equity | Long | USA |
Cigna Holding Co | 2.23 mm | 8.07 k shares | 1.36 | Common equity | Long | USA |
BDX Becton, Dickinson and Company | 2.05 mm | 9.03 k shares | 1.25 | Common equity | Long | USA |
BPMC Blueprint Medicines Corporation | 1.90 mm | 21.84 k shares | 1.16 | Common equity | Long | USA |
PEN Penumbra, Inc. | 1.85 mm | 7.79 k shares | 1.13 | Common equity | Long | USA |
ASND Ascendis Pharma A/S | 1.78 mm | 12.95 k shares | 1.08 | Common equity | Long | Denmark |
ONC BeiGene, Ltd. | 1.74 mm | 9.42 k shares | 1.06 | Common equity | Long | Cayman Islands |
SNY Sanofi | 1.68 mm | 34.90 k shares | 1.02 | Common equity | Long | France |
HCA HCA Healthcare, Inc. | 1.26 mm | 4.21 k shares | 0.77 | Common equity | Long | USA |
UTHR United Therapeutics Corporation | 1.25 mm | 3.55 k shares | 0.76 | Common equity | Long | USA |
SRRK Scholar Rock Holding Corporation | 1.21 mm | 27.97 k shares | 0.74 | Common equity | Long | USA |
INVESCO GOVERNMENT & AGENCY PORTFOLIO OPEN-END FUND USD | 1.21 mm | 1.21 mm principal | 0.74 | Short-term investment vehicle | Long | USA |
PCVX Vaxcyte, Inc. | 1.18 mm | 14.38 k shares | 0.72 | Common equity | Long | USA |
SMMT Summit Therapeutics Inc. | 1.18 mm | 65.86 k shares | 0.72 | Common equity | Long | USA |
MOH Molina Healthcare, Inc. | 1.12 mm | 3.84 k shares | 0.68 | Common equity | Long | USA |
MLTX MoonLake Immunotherapeutics | 1.12 mm | 20.62 k shares | 0.68 | Common equity | Long | Cayman Islands |
NTRA Natera, Inc. | 1.10 mm | 6.96 k shares | 0.67 | Common equity | Long | USA |
THC Tenet Healthcare Corporation | 1.07 mm | 8.47 k shares | 0.65 | Common equity | Long | USA |
Sonova Holding AG (Registered)
|
1.00 mm | 3.08 k shares | 0.61 | Common equity | Long | Switzerland |
DREYFUS TREASURY OBLIGATIONS CASH MANAGEMENT FUND OPEN-END FUND USD | 1.00 mm | 1.00 mm principal | 0.61 | Short-term investment vehicle | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 982.80 k | 7.20 k shares | 0.60 | Common equity | Long | USA |
RVMD Revolution Medicines, Inc. | 976.80 k | 22.33 k shares | 0.59 | Common equity | Long | USA |
RNA Avidity Biosciences, Inc. | 968.97 k | 33.32 k shares | 0.59 | Common equity | Long | USA |
Biohaven Ltd.
|
925.57 k | 24.78 k shares | 0.56 | Common equity | Long | Virgin Islands (British) |
Chugai Pharmaceutical Co. Ltd.
|
907.24 k | 20.60 k shares | 0.55 | Common equity | Long | Japan |
EXAS Exact Sciences Corporation | 903.76 k | 16.08 k shares | 0.55 | Common equity | Long | USA |
ACLX Arcellx, Inc. | 900.11 k | 11.74 k shares | 0.55 | Common equity | Long | USA |
EW Edwards Lifesciences Corporation | 872.30 k | 11.78 k shares | 0.53 | Common equity | Long | USA |
VRNA Verona Pharma plc | 870.05 k | 18.74 k shares | 0.53 | Common equity | Long | UK |
A Agilent Technologies, Inc. | 821.49 k | 6.12 k shares | 0.50 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals, Inc. | 800.18 k | 15.65 k shares | 0.49 | Common equity | Long | USA |
CNTA Centessa Pharmaceuticals plc | 781.99 k | 46.69 k shares | 0.48 | Common equity | Long | UK |
KYMR Kymera Therapeutics, Inc. | 740.55 k | 18.41 k shares | 0.45 | Common equity | Long | USA |
TECH Bio-Techne Corporation | 738.38 k | 10.25 k shares | 0.45 | Common equity | Long | USA |
VERA Vera Therapeutics, Inc. | 677.15 k | 16.01 k shares | 0.41 | Common equity | Long | USA |
IDXX IDEXX Laboratories, Inc. | 674.73 k | 1.63 k shares | 0.41 | Common equity | Long | USA |
MDGL Madrigal Pharmaceuticals, Inc. | 658.49 k | 2.13 k shares | 0.40 | Common equity | Long | USA |
Zai Lab Ltd.
|
647.94 k | 24.74 k shares | 0.39 | Common equity | Long | Cayman Islands |
DGX Quest Diagnostics Incorporated | 623.50 k | 4.13 k shares | 0.38 | Common equity | Long | USA |
RVTY Revvity, Inc. | 614.52 k | 5.51 k shares | 0.37 | Common equity | Long | USA |
CAH Cardinal Health, Inc. | 576.45 k | 4.87 k shares | 0.35 | Common equity | Long | USA |
CNC Centene Corporation | 555.94 k | 9.18 k shares | 0.34 | Common equity | Long | USA |
PTGX Protagonist Therapeutics, Inc. | 552.10 k | 14.30 k shares | 0.34 | Common equity | Long | USA |
OSCR Oscar Health, Inc. | 545.99 k | 40.62 k shares | 0.33 | Common equity | Long | USA |
Novocure Ltd.
|
536.97 k | 18.02 k shares | 0.33 | Common equity | Long | Jersey |
COR Cencora | 527.55 k | 2.35 k shares | 0.32 | Common equity | Long | USA |
KRYS Krystal Biotech, Inc. | 525.12 k | 3.35 k shares | 0.32 | Common equity | Long | USA |
MCK McKesson Corporation | 524.89 k | 921.00 shares | 0.32 | Common equity | Long | USA |
NVO Novo Nordisk A/S | 522.06 k | 6.07 k shares | 0.32 | Common equity | Long | Denmark |
INCY Incyte Corporation | 521.82 k | 7.56 k shares | 0.32 | Common equity | Long | USA |
HOLX Hologic, Inc. | 521.07 k | 7.23 k shares | 0.32 | Common equity | Long | USA |
PRCT PROCEPT BioRobotics Corporation | 509.45 k | 6.33 k shares | 0.31 | Common equity | Long | USA |
Sartorius AG (Preference)
|
504.71 k | 2.26 k shares | 0.31 | Common equity | Long | Germany |
Alkermes plc
|
504.22 k | 17.53 k shares | 0.31 | Common equity | Long | Ireland |
RGEN Repligen Corporation | 502.78 k | 3.49 k shares | 0.31 | Common equity | Long | USA |
DXCM DexCom, Inc. | 492.60 k | 6.33 k shares | 0.30 | Common equity | Long | USA |
APGE Apogee Therapeutics, Inc. | 480.45 k | 10.61 k shares | 0.29 | Common equity | Long | USA |
BTSG BrightSpring Health Services, Inc. Common Stock | 480.33 k | 28.21 k shares | 0.29 | Common equity | Long | USA |
AGIO Agios Pharmaceuticals, Inc. | 480.12 k | 14.61 k shares | 0.29 | Common equity | Long | USA |
IMCR Immunocore Holdings plc | 464.27 k | 15.74 k shares | 0.28 | Common equity | Long | UK |
IONS Ionis Pharmaceuticals, Inc. | 461.02 k | 13.19 k shares | 0.28 | Common equity | Long | USA |
SWTX SpringWorks Therapeutics, Inc. | 450.76 k | 12.48 k shares | 0.27 | Common equity | Long | USA |
CYTK Cytokinetics, Incorporated | 447.49 k | 9.51 k shares | 0.27 | Common equity | Long | USA |
DNLI Denali Therapeutics Inc. | 433.30 k | 21.26 k shares | 0.26 | Common equity | Long | USA |
MASI Masimo Corporation | 395.40 k | 2.39 k shares | 0.24 | Common equity | Long | USA |
COO The Cooper Companies, Inc. | 382.61 k | 4.16 k shares | 0.23 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc. | 381.32 k | 15.38 k shares | 0.23 | Common equity | Long | USA |
BNTX BioNTech SE | 378.66 k | 3.32 k shares | 0.23 | Common equity | Long | Germany |
BMRN BioMarin Pharmaceutical Inc. | 377.88 k | 5.75 k shares | 0.23 | Common equity | Long | USA |
AKRO Akero Therapeutics, Inc. | 367.70 k | 13.22 k shares | 0.22 | Common equity | Long | USA |
Teva Pharmaceutical Industries Ltd.
|
363.66 k | 16.50 k shares | 0.22 | Common equity | Long | Israel |
BIIB Biogen Inc. | 363.19 k | 2.38 k shares | 0.22 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 363.11 k | 8.63 k shares | 0.22 | Common equity | Long | USA |
PRAX Praxis Precision Medicines, Inc. | 360.48 k | 4.68 k shares | 0.22 | Common equity | Long | USA |
JANX Janux Therapeutics, Inc. | 359.63 k | 6.72 k shares | 0.22 | Common equity | Long | USA |
WaVe Life Sciences Ltd.
|
348.55 k | 28.18 k shares | 0.21 | Common equity | Long | Singapore |
LEGN Legend Biotech Corporation | 339.26 k | 10.43 k shares | 0.21 | Common equity | Long | Cayman Islands |
NUVL Nuvalent, Inc. | 325.18 k | 4.15 k shares | 0.20 | Common equity | Long | USA |
HUM Humana Inc. | 321.70 k | 1.27 k shares | 0.20 | Common equity | Long | USA |
ICON plc
|
319.60 k | 1.52 k shares | 0.19 | Common equity | Long | Ireland |
XNCR Xencor, Inc. | 314.96 k | 13.71 k shares | 0.19 | Common equity | Long | USA |
LNTH Lantheus Holdings, Inc. | 312.39 k | 3.49 k shares | 0.19 | Common equity | Long | USA |
REPL Replimune Group, Inc. | 309.37 k | 25.55 k shares | 0.19 | Common equity | Long | USA |
UCB SA
|
304.41 k | 1.53 k shares | 0.19 | Common equity | Long | Belgium |
BLACKROCK LIQUIDITY FEDFUND OPEN-END FUND USD | 300.00 k | 300.00 k principal | 0.18 | Short-term investment vehicle | Long | USA |
CRGX CARGO Therapeutics, Inc. Common Stock | 282.13 k | 19.57 k shares | 0.17 | Common equity | Long | USA |
SLNO Soleno Therapeutics, Inc. | 276.62 k | 6.15 k shares | 0.17 | Common equity | Long | USA |
LENZ LENZ Therapeutics, Inc. | 276.05 k | 9.56 k shares | 0.17 | Common equity | Long | USA |
TARS Tarsus Pharmaceuticals, Inc. | 272.64 k | 4.92 k shares | 0.17 | Common equity | Long | USA |
IMNM Immunome, Inc. | 270.80 k | 25.50 k shares | 0.16 | Common equity | Long | USA |
IRON Disc Medicine, Inc. | 266.03 k | 4.20 k shares | 0.16 | Common equity | Long | USA |
CLDX Celldex Therapeutics, Inc. | 263.64 k | 10.43 k shares | 0.16 | Common equity | Long | USA |
BCYC Bicycle Therapeutics plc | 260.60 k | 18.61 k shares | 0.16 | Common equity | Long | UK |
BRKR Bruker Corporation | 257.75 k | 4.40 k shares | 0.16 | Common equity | Long | USA |
Merus NV
|
257.35 k | 6.12 k shares | 0.16 | Common equity | Long | Netherlands |
RYTM Rhythm Pharmaceuticals, Inc. | 257.06 k | 4.59 k shares | 0.16 | Common equity | Long | USA |
GPCR Structure Therapeutics Inc. | 251.92 k | 9.29 k shares | 0.15 | Common equity | Long | Cayman Islands |
RAPP Rapport Therapeutics, Inc. Common Stock | 244.40 k | 13.78 k shares | 0.15 | Common equity | Long | USA |
ALHC Alignment Healthcare, Inc. | 242.47 k | 21.55 k shares | 0.15 | Common equity | Long | USA |
CGON CG Oncology, Inc. Common stock | 227.46 k | 7.93 k shares | 0.14 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals, Inc. | 213.14 k | 16.96 k shares | 0.13 | Common equity | Long | USA |
TXG 10x Genomics, Inc. | 207.96 k | 14.48 k shares | 0.13 | Common equity | Long | USA |
DYN Dyne Therapeutics, Inc. | 198.26 k | 8.41 k shares | 0.12 | Common equity | Long | USA |
IDYA IDEAYA Biosciences, Inc. | 187.17 k | 7.28 k shares | 0.11 | Common equity | Long | USA |
APLS Apellis Pharmaceuticals, Inc. | 183.96 k | 5.77 k shares | 0.11 | Common equity | Long | USA |
ARVN Arvinas, Inc. | 167.30 k | 8.73 k shares | 0.10 | Common equity | Long | USA |
IOVA Iovance Biotherapeutics, Inc. | 157.55 k | 21.29 k shares | 0.10 | Common equity | Long | USA |
GLUE Monte Rosa Therapeutics, Inc. | 155.34 k | 22.38 k shares | 0.09 | Common equity | Long | USA |
SYRE Spyre Therapeutics, Inc. | 154.95 k | 6.66 k shares | 0.09 | Common equity | Long | USA |
VEEV Veeva Systems Inc. | 147.18 k | 700.00 shares | 0.09 | Common equity | Long | USA |
PLRX Pliant Therapeutics, Inc. | 138.55 k | 10.52 k shares | 0.08 | Common equity | Long | USA |
MBX MBX Biosciences, Inc. Common Stock | 138.28 k | 7.50 k shares | 0.08 | Common equity | Long | USA |
Prothena Corp. plc
|
137.32 k | 9.91 k shares | 0.08 | Common equity | Long | Ireland |
Immatics NV
|
134.68 k | 18.94 k shares | 0.08 | Common equity | Long | Netherlands |
ORKA Oruka Therapeutics Inc. | 133.66 k | 6.89 k shares | 0.08 | Common equity | Long | USA |
ALLO Allogene Therapeutics, Inc. | 130.10 k | 61.08 k shares | 0.08 | Common equity | Long | USA |
BCAX Bicara Therapeutics Inc. Common Stock | 129.36 k | 7.43 k shares | 0.08 | Common equity | Long | USA |
KOD Kodiak Sciences Inc. | 128.35 k | 12.90 k shares | 0.08 | Common equity | Long | USA |
Pharvaris NV
|
127.60 k | 6.66 k shares | 0.08 | Common equity | Long | Netherlands |
ORIC ORIC Pharmaceuticals, Inc. | 126.70 k | 15.70 k shares | 0.08 | Common equity | Long | USA |
GERN Geron Corporation | 125.54 k | 35.46 k shares | 0.08 | Common equity | Long | USA |
SEPN Septerna, Inc. Common Stock | 121.62 k | 5.31 k shares | 0.07 | Common equity | Long | USA |
Helix Acquisition Corp. II, Class A
|
117.53 k | 11.19 k shares | 0.07 | Common equity | Long | Cayman Islands |
TRDA Entrada Therapeutics, Inc. | 115.24 k | 6.67 k shares | 0.07 | Common equity | Long | USA |
RLAY Relay Therapeutics, Inc. | 107.91 k | 26.19 k shares | 0.07 | Common equity | Long | USA |
OCUL Ocular Therapeutix, Inc. | 88.82 k | 10.40 k shares | 0.05 | Common equity | Long | USA |
EHC Encompass Health Corporation | 83.12 k | 900.00 shares | 0.05 | Common equity | Long | USA |
Sensorion SA
|
82.94 k | 125.89 k shares | 0.05 | Common equity | Long | France |
EYPT EyePoint Pharmaceuticals, Inc. | 82.76 k | 11.11 k shares | 0.05 | Common equity | Long | USA |
VYGR Voyager Therapeutics, Inc. | 80.33 k | 14.17 k shares | 0.05 | Common equity | Long | USA |
ANNX Annexon, Inc. | 78.08 k | 15.22 k shares | 0.05 | Common equity | Long | USA |
IGMS IGM Biosciences, Inc. | 74.32 k | 12.16 k shares | 0.05 | Common equity | Long | USA |
VRDN Viridian Therapeutics, Inc. | 72.85 k | 3.80 k shares | 0.04 | Common equity | Long | USA |
DAWN Day One Biopharmaceuticals, Inc. | 67.97 k | 5.37 k shares | 0.04 | Common equity | Long | USA |
SANA Sana Biotechnology, Inc. | 63.17 k | 38.76 k shares | 0.04 | Common equity | Long | USA |
KROS Keros Therapeutics, Inc. | 60.91 k | 3.85 k shares | 0.04 | Common equity | Long | USA |
AURA Aura Biosciences, Inc. | 59.98 k | 7.30 k shares | 0.04 | Common equity | Long | USA |
LYEL Lyell Immunopharma, Inc. | 59.89 k | 93.57 k shares | 0.04 | Common equity | Long | USA |
ANAB AnaptysBio, Inc. | 59.58 k | 4.50 k shares | 0.04 | Common equity | Long | USA |
WGS GeneDx Holdings Corp. | 57.18 k | 744.00 shares | 0.03 | Common equity | Long | USA |
ZNTL Zentalis Pharmaceuticals, Inc. | 55.77 k | 18.41 k shares | 0.03 | Common equity | Long | USA |
SAGE Sage Therapeutics, Inc. | 52.88 k | 9.74 k shares | 0.03 | Common equity | Long | USA |
IMRX Immuneering Corporation | 49.56 k | 22.53 k shares | 0.03 | Common equity | Long | USA |
MGNX MacroGenics, Inc. | 48.43 k | 14.90 k shares | 0.03 | Common equity | Long | USA |
NxStage Medical, Inc. | 46.72 k | 25.53 k shares | 0.03 | Common equity | Long | USA |
UroGen Pharma Ltd.
|
41.54 k | 3.90 k shares | 0.03 | Common equity | Long | Israel |
NGNE Neurogene Inc. | 36.58 k | 1.60 k shares | 0.02 | Common equity | Long | USA |
OBIO Orchestra BioMed Holdings, Inc. | 36.18 k | 9.05 k shares | 0.02 | Common equity | Long | USA |
THRD Third Harmonic Bio, Inc. | 35.78 k | 3.48 k shares | 0.02 | Common equity | Long | USA |
CRBP Corbus Pharmaceuticals Holdings, Inc. | 35.40 k | 3.00 k shares | 0.02 | Common equity | Long | USA |
ANRO Alto Neuroscience, Inc. | 33.80 k | 7.99 k shares | 0.02 | Common equity | Long | USA |
GBIO Generation Bio Co. | 31.95 k | 30.14 k shares | 0.02 | Common equity | Long | USA |
KYTX Kyverna Therapeutics, Inc. | 24.52 k | 6.56 k shares | 0.01 | Common equity | Long | USA |
ALEC Alector, Inc. | 24.29 k | 12.85 k shares | 0.01 | Common equity | Long | USA |
CABA Cabaletta Bio, Inc. | 14.53 k | 6.40 k shares | 0.01 | Common equity | Long | USA |
PRLD Prelude Therapeutics Incorporated | 13.96 k | 10.95 k shares | 0.01 | Common equity | Long | USA |
SPOT Spotify Technology S.A. | 13.22 k | 1.35 k shares | 0.01 | Common equity | Long | USA |
CLYM Climb Bio, Inc. | 11.70 k | 6.50 k shares | 0.01 | Common equity | Long | USA |
WGS GeneDx Holdings Corp. | 533.12 | 3.33 k shares | 0.00 | DO | N/A | USA |
RVMD Revolution Medicines, Inc. | 505.32 | 3.13 k shares | 0.00 | DO | N/A | USA |
SLGCW SomaLogic, Inc. | 0 | 1.42 k shares | 0.00 | DO | N/A | USA |